Related references
Note: Only part of the references are listed.Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances
Emma L. Smith et al.
FRONTIERS IN IMMUNOLOGY (2018)
DNA sequences from mobile genetic elements, a hidden half of the human genome
Julie Medina et al.
M S-MEDECINE SCIENCES (2017)
Mobile DNA in Health and Disease
Haig H. Kazazian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis
Yong-chao Qiao et al.
PLOS ONE (2017)
An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes
Sandrine Levet et al.
JCI INSIGHT (2017)
Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development
Friedrich Mittermayer et al.
CURRENT DIABETES REVIEWS (2017)
Celiac Disease Increases Risk of Thyroid Disease in Patients With Type 1 Diabetes: A Nationwide Cohort Study
Matthew Kurien et al.
DIABETES CARE (2016)
T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review
Iria Gomez-Tourino et al.
JOURNAL OF AUTOIMMUNITY (2016)
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment
Alexandra Madeira et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study
Francois Curtin et al.
MABS (2016)
Regulatory evolution of innate immunity through co-option of endogenous retroviruses
Edward B. Chuong et al.
SCIENCE (2016)
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design
Francois Curtin et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis
Jack van Horssen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Raphael Faucard et al.
EBIOMEDICINE (2016)
Immunotherapies currently in development for the treatment of type 1 diabetes
Ian C. Davis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up
Tobias Derfuss et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology
Prudence Tettey et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Treatment Against Human Endogenous Retrovirus: A Possible Personalized Medicine Approach for Multiple Sclerosis
Francois Curtin et al.
MOLECULAR DIAGNOSIS & THERAPY (2015)
Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?
Sandra Lord et al.
PHARMACOLOGICAL RESEARCH (2015)
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein
Francois Curtin et al.
MABS (2015)
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients
Tobias Derfuss et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS
Maria Zimmermann et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
L1 Retrotransposons and Somatic Mosaicism in the Brain
Sandra R. Richardson et al.
ANNUAL REVIEW OF GENETICS, VOL 48 (2014)
Coxsackievirus B1 Is Associated With Induction of β-Cell Autoimmunity That Portends Type 1 Diabetes
Olli H. Laitinen et al.
DIABETES (2014)
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
Sefina Arif et al.
DIABETES (2014)
Thyroid autoimmunity in Type 1 diabetes: systematic review and meta-analysis
C. B. Shun et al.
DIABETIC MEDICINE (2014)
Rheumatoid Arthritis is Associated with IgG Antibodies to Human Endogenous Retrovirus Gag Matrix: A Potential Pathogenic Mechanism of Disease?
Paul N. Nelson et al.
JOURNAL OF RHEUMATOLOGY (2014)
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study
Giannina Arru et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
The enemy within: endogenous retroelements and autoimmune disease
Hannah E. Volkman et al.
NATURE IMMUNOLOGY (2014)
Human Endogenous Retrovirus Type W Envelope Protein Inhibits Oligodendroglial Precursor Cell Differentiation
David Kremer et al.
ANNALS OF NEUROLOGY (2013)
Progress in immune-based therapies for type 1 diabetes
M. von Herrath et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Immunological pathways to β-cell damage in Type 1 diabetes
M. Peakman
DIABETIC MEDICINE (2013)
Human Endogenous Retrovirus Protein Activates Innate Immunity and Promotes Experimental Allergic Encephalomyelitis in Mice
Herve Perron et al.
PLOS ONE (2013)
GNbAC1, a Humanized Monoclonal Antibody Against the Envelope Protein of Multiple Sclerosis-Associated Endogenous Retrovirus: A First-in-Humans Randomized Clinical Study
Francois Curtin et al.
CLINICAL THERAPEUTICS (2012)
Infection as a cause of type 1 diabetes?
Urs Christen et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes
Min Li et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease
Herve Perron et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Endogenous viruses: insights into viral evolution and impact on host biology
Cedric Feschotte et al.
NATURE REVIEWS GENETICS (2012)
Expression and Activation by Epstein Barr Virus of Human Endogenous Retroviruses-W in Blood Cells and Astrocytes: Inference for Multiple Sclerosis
Giuseppe Mameli et al.
PLOS ONE (2012)
Identification of Active Loci of a Human Endogenous Retrovirus in Neurons of Patients with Amyotrophic Lateral Sclerosis
Renee Douville et al.
ANNALS OF NEUROLOGY (2011)
Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis
Humberto M. Garay-Malpartida et al.
BMC IMMUNOLOGY (2011)
T cell receptor recognition of self and foreign antigens in the induction of autoimmunity
Kai W. Wucherpfennig et al.
SEMINARS IN IMMUNOLOGY (2011)
Enteroviruses in the pathogenesis of type 1 diabetes
Sisko Tauriainen et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies
Wing-Chi G. Yeung et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The Human Endogenous Retrovirus Link between Genes and Environment in Multiple Sclerosis and in Multifactorial Diseases Associating Neuroinflammation
Herve Perron et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2010)
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis
S. Sotgiu et al.
MULTIPLE SCLEROSIS (2010)
The enemy within: dormant retroviruses awaken
Michael E. Engel et al.
NATURE MEDICINE (2010)
Endogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis
Herve Perron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Incidence and prevalence of CIDP and the association of diabetes mellitus
R. S. Laughlin et al.
NEUROLOGY (2009)
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE
Andras Perl et al.
AUTOIMMUNITY (2008)
Endogenous Retrovirus Type W GAG and Envelope Protein Antigenemia in Serum of Schizophrenic Patients
Herve Perron et al.
BIOLOGICAL PSYCHIATRY (2008)
Inhibition of multiple sclerosis-associated retrovirus as biomarker of interferon therapy
Giuseppe Mameli et al.
JOURNAL OF NEUROVIROLOGY (2008)
Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus
Hannu Juvonen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses
Alexandre Rolland et al.
JOURNAL OF IMMUNOLOGY (2006)
Divergent patterns of recent retroviral integrations in the human and chimpanzee genomes: Probable transmissions between other primates and chimpanzees
P Jern et al.
JOURNAL OF VIROLOGY (2006)
Involvement of human intracisternal A-type retroviral particles in autoimmunity
DM Sander et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2005)
Correlation between disease severity and in vitro cytokine production mediated by MSRV (Multiple Sclerosis associated RetroViral element) envelope protein in patients with multiple sclerosis
A Rolland et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells
M Vives-Pi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model
R Firouzi et al.
JOURNAL OF NEUROVIROLOGY (2003)
Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vβ16 T-lymphocyte activation
H Perron et al.
VIROLOGY (2001)
Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation
G Arad et al.
NATURE MEDICINE (2000)
Share Paper
